Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2022-07-11 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by 瑞康医药集团股份有限公司. It discusses the unusual price movements of the company's stock over two trading days, the company's investigation and verification of the situation, confirmation that no undisclosed material information exists, and a risk warning to investors. The document is short (1318 characters) and serves as a regulatory disclosure about stock price volatility rather than a financial report or earnings release. It does not contain financial statements, management discussion, or detailed financial data. It is a typical regulatory announcement related to stock trading behavior and compliance with stock exchange rules. Therefore, it fits best under Regulatory Filings (RNS).
2022-07-11 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by 瑞康医药集团股份有限公司. It discusses the unusual price movements of the company's stock over two consecutive trading days, the company's investigation into the cause, confirmation of no undisclosed material information, and a risk warning to investors. There is no financial data, no report attached or referenced as being published, and no mention of annual or quarterly results, management changes, or other report types. The document is a regulatory announcement related to stock price behavior and compliance with disclosure rules, fitting the category of a Regulatory Filing (RNS). The document length is short (1571 characters), and it is not a report publication announcement or a financial report itself.
2022-07-07 Chinese
关于公司提供担保进展情况的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the progress of guarantees provided by the company and its subsidiaries, including specific guarantee amounts, relationships, financial conditions of the guaranteed parties, and cumulative guarantee amounts. It includes tables of financial data related to the guarantees but does not present a full financial report or earnings results. The document is a formal public announcement about the company's guarantee activities, which is a type of regulatory disclosure. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update. It is not a certification or a short notice about a report publication. The content aligns best with a Regulatory Filing (RNS) as it is a compliance disclosure about guarantees and related financial information without being a full financial report or other specific filing type.
2022-06-15 Chinese
关于公司高管退休的公告
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the retirement of a company's senior executive (vice general manager). It includes statements about the executive's retirement, compliance with company law and stock exchange regulations, and expresses gratitude for the executive's contributions. There is no financial data, no mention of financial results, no voting results, no legal proceedings, no capital changes, and no other report types. The document is clearly about a management change, specifically a senior management retirement. Therefore, it fits best under the category 'Board/Management Information (MANG)'. The document length is short and focused solely on management change, supporting this classification with high confidence.
2022-06-02 Chinese
天圆全会计师事务所（特殊普通合伙）关于深圳证券交易所《关于对瑞康医药集团股份有限公司的年报问询函》的回复
Audit Report / Information Classification · 95% confidence The document is a detailed response from an accounting firm to the Shenzhen Stock Exchange regarding inquiries about the 2021 annual report of a company. It includes extensive audit procedures, findings related to control over subsidiaries, financial data analysis, internal control assessments, and detailed disclosures about receivables and related risks. The content is focused on audit findings and compliance with accounting standards, specifically addressing issues raised about the annual report. The document is lengthy (15,000 characters) and contains substantive financial and audit information rather than just an announcement or certification. Therefore, it fits the category of an Audit Report / Information (AR), as it is a standalone audit-related document discussing audit procedures, evidence, and opinions related to the annual report but is not the annual report itself. FY 2021
2022-05-23 Chinese
2021年年度股东大会的律师见证法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2021 Annual General Meeting (AGM) of 瑞康医药集团股份有限公司. It details the procedures of the AGM, including the convening, attendance, agenda items, voting procedures, and results. The document does not contain financial statements or detailed financial performance data but focuses on the legality and validity of the AGM process and resolutions. This type of document is typically classified as AGM Information (AGM-R), as it relates to materials shared or produced in connection with the AGM, specifically a legal opinion on the AGM proceedings and voting results. The document length (6100 characters) and content confirm it is not a brief announcement or a full annual report but a detailed legal opinion on the AGM.
2022-05-23 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.